Zacks Investment Management Fulgent Genetics, Inc. Transaction History

Zacks Investment Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $760,454 - $1.13 Million	-10,157 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$66.8 - $100.45 $600,732 - $903,346	-8,993 Reduced 46.96%	10,157 $937,000
Q1 2021 May 17, 2021	BUY	$59.3 - $183.85 $1.14 Million - $3.52 Million	19,150 New	19,150 $1.85 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.